New RNA flu vaccine could be a Game-Changer – early trial underway

NCT ID NCT05227001

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Pfizer is testing a new type of flu vaccine called a self-amplifying RNA (saRNA) vaccine. This early study involves 440 healthy adults aged 18 to 49. Participants receive either the saRNA vaccine, a licensed flu shot, or a placebo. The main goal is to check safety and side effects, with a secondary look at immune response. The trial is already completed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

self-amplifying RNA (saRNA) flu vaccine

What this could lead to

If successful, this could lead to a more effective flu vaccine that requires lower doses and provides stronger protection.

What could go wrong

This is an early Phase 1 trial focused on safety, not yet proving the vaccine works. The saRNA technology is new, and side effects or limited immune response are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

influenza prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Pharma CR, LLC

    Miami, Florida, 33147, United States

  • Arizona Heart Rhythm Center

    Phoenix, Arizona, 85016, United States

  • Benchmark Research

    Austin, Texas, 78705, United States

  • CTI Clinical Research Center

    Cincinnati, Ohio, 45212, United States

  • Coastal Carolina Research Center

    North Charleston, South Carolina, 29405, United States

  • Comprehensive Cardiology Consultants

    Pembroke Pines, Florida, 33028, United States

  • DM Clinical Research, Martin Diagnostic Clinic

    Tomball, Texas, 77375, United States

  • Diablo Clinical Research, Inc.

    Walnut Creek, California, 94598, United States

  • Eric S. Tiblier, MD

    Austin, Texas, 78705, United States

  • Finlay Medical Research

    Greenacres City, Florida, 33467, United States

  • Great Lakes Clinical Trials - Andersonville

    Chicago, Illinois, 60640, United States

  • Hope Research Institute

    Phoenix, Arizona, 85018, United States

  • Miami Clinical Research

    Miami, Florida, 33155, United States

  • Mount Sinai Hospital

    Miami Beach, Florida, 33140, United States

  • NYU Langone Health

    New York, New York, 10016, United States

  • Panax Clinical Research

    Miami Lakes, Florida, 33014, United States

  • Pines Care Research Center, LLC

    Pembroke Pines, Florida, 33024, United States

  • Pinnacle Health Care Center

    Pembroke Pines, Florida, 33024, United States

  • Pioneer Heart Institute

    Lincoln, Nebraska, 68506, United States

  • SUNY Upstate Medical University

    Syracuse, New York, 13215, United States

  • SUNY Upstate Medical University Global Health Laboratory

    Syracuse, New York, 13210, United States

  • SUNY Upstate Medical University Institute for Global Health

    Syracuse, New York, 13215, United States

  • The Pain Center of Arizona

    Phoenix, Arizona, 85018, United States

  • Velocity Clinical Research, Omaha

    Omaha, Nebraska, 68134, United States